Outcome in children with purpura fulminans: Report on 16 patients

American Journal of Hematology

Volumn 80, Issue 1, 2005, Pages 20-25

  Gürgey, Aytemiz ^a   Aytac, Selin ^a   Kanra, Guler ^a   Secmeer, Gulten ^a   Ceyhan, Mehmet ^a   Altay, Cigdem ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Amputation; Factor V g1391A mutation; Meningococcemia; Purpura fulminans; Staphylococcal infection

Indexed keywords

ALANINE; BLOOD CLOTTING FACTOR 5 LEIDEN; FRESH FROZEN PLASMA; GLYCINE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

AGE; AMINO ACID SUBSTITUTION; AMPUTATION; ARTICLE; BACTERIAL INFECTION; CHILD; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FULMINATING PURPURA; GENE MUTATION; HEALTH CARE; HUMAN; IMMUNIZATION; INFANT; LETHALITY; MALE; MENINGOCOCCEMIA; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; RISK FACTOR; SKIN GRAFT; STAPHYLOCOCCUS INFECTION; SURVIVAL RATE; THROMBOSIS; TREATMENT INDICATION; VIRUS INFECTION;

AMPUTATION; CHILD; CHILD, PRESCHOOL; FEMALE; HOMOZYGOTE; HUMANS; INFANT; MALE; PURPURA, SCHOENLEIN-HENOCH; RETROSPECTIVE STUDIES; RISK FACTORS; SKIN TRANSPLANTATION; TREATMENT OUTCOME;

EID: 24344501189     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20435     Document Type: Article

References (21)

1. Smith OP, White B. Infectious purpura fulminans: diagnosis and treatment. Br J Haematol 1999;104:202-207.
2. Nakayama T, Matsushita T, Hidano H, et al. A case of purpura fulminans is caused by homozygous A8857 mutation (protein C-Nagoya) and successfully treated with activated protein C concentrate. Br J Haematol 2000;110:727-730.
3. Dogan Y, Aygen D, Yilmaz Y, et al. Severe protein S deficiency associated with heterozygous factor V Leiden mutation in a child with purpura fulminans. Pediatr Hematol Oncol 2003;20:1-5.
4. Sackesen C, Secmeer G, Gurgey A, et al. Homozygous factor V Leiden mutation in a child with meningococcal purpura fulminans. Pediatr Infect Dis J 1998;17:87.
5. Bonduel M, Hepner M, Sciuccati G, Pieroni G, Torres AF, Frontroth JP. Infectious purpura fulminans in children. Int J Pediatr Hematol Oncol 1998;5:21-27.
6. Ozbek N, Atac FB, Verdi H, Kayiran SM. Purpura fulminans in a child with combined heterozygous prothrombin G20210A and factor V Leiden mutations. Ann Hematol 2003;82:118-120.
7. Unal S, Balta G, Duru F, Gumruk F, Altay C, Gurgey A. Clinical and laboratory evaluation of Turkish children with thrombosis for homozygous factor V G1691A mutation. Blood Coagul Fibrinolysis 2004;15:343-346.
8. Texereau J, Pene F, Chiche JD, Rousseau C, Mira JP. Importance of hemostatic gene polymorphisms for susceptibility to and outcome of severe sepsis. Crit Care Med 2004;32:S313-S319.
9. Josephson C, Nuss R, Jacobsan L, et al. The varicella-autoantibody syndrome. Pediatr Res 2001;50:345-352.
10. Manco-Johnson MJ, Nuss R, Key N, et al. Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis. J Pediatr 1996;128:319-323.
11. Darmstadt GL. Acute infectious purpura fulminans: pathogenesis and medical management. Pediatr Dermatol 1998;15:169-183.
12. Kondaveeti S, Hibberd ML, Booy R, Nadel S, Levin M. Effect of factor V Leiden mutation on the severity of meningococcal disease. Pediatr Infect Dis J 1999;18:893-896.
13. Tezcan I, Xu W, Gurgey A, et al. Congenital erythropoietic porphyria successfully treated by allogeneic bone marrow transplantation. Blood 1998;92:4053-4058.
14. Bertina RM, Koeleman BP, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-67.
15. Poort SR, Rosendaal FR, Reitsma PH, Breton RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-3703.
16. Gurgey A, Mesci L. The prevalence of factor V Leiden (1691 G-A) mutation in Turkey. Turk J Pediatr 1997;39:313-315.
17. Carpenter CT, Kaiser AB. Purpura fulminans in pneumococcal sepsis: case report and review. Scand J Infect Dis 1997;29:479-483.
18. Kuppermann N, Inkelis S, Saladino R. The role of heparin in the prevention of extremity and digit necrosis in meningococcal purpura fulminans. Pediatr Infect Dis J 1994;13:867-887.
19. rd. Adult purpura fulminans and digital necrosis associated with sepsis and the factor V mutation. JAMA 1998;280(21):1829-1830.
20. Smith OP, White B, Vaughan D, et al. Use of protein C concentrate, heparin and haemodiafiltration in meningococcus-induced purpura fulminans. Lancet 1997;350:1590-1591.
21. Ettingshausen CE, Veldmann A, Beeg T, Schneider W, Jager G, Kreuz W. Replacement therapy with protein C concentrate in infants and adolescents with meningococcal sepsis and purpura fulminans. Semin Thromb Hemost 1999;25:537-541.